 Home > Medical News > Latest Medical News > Sichuan pharmaceutical companies attack $12 billion star antineoplastic drug

Sichuan pharmaceutical companies attack $12 billion star antineoplastic drug

 Last Update: 2021-12-09
 Source: Internet
 Author: User

Tags

asl 1 100

reddy labs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, the official website of CDE showed that lenalidomide capsules produced by Sichuan Meidakang Huakang Pharmaceutical Co.
, Ltd.
have been accepted for production of imitation 4 types
.

According to data from Meinenet, the global sales of lenalidomide capsules in 2020 will exceed 12 billion U.

Lenalidomide is a synthetic glutamate derivative, which has the effect of inhibiting angiogenesis and immune regulation
.

Due to the advantages of good therapeutic effect, high safety and convenient administration method, lenalidomide has become the first choice for targeted therapy of multiple myeloma

Sales of terminal lenalidomide capsules in Chinese public medical institutions in recent years (unit: 100 million yuan)

Source: The terminal competition pattern of China's public medical institutions

In 2019, Bristol-Myers Squibb acquired Xinji to obtain lenalidomide capsules.
In 2020, the global sales of this product exceeded 12 billion U.
S.
dollars
.

According to data from Minai.

Source: Meinenet MED2.
0 Chinese Drug Evaluation Database

Up to now, there are 6 domestic lenalidomide capsule manufacturers, of which 5 domestic pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group, Qilu Pharmaceutical, and Jiangsu Hausen Pharmaceutical, have all been evaluated
.

In addition, the Changzhou Pharmaceutical Factory of this product has entered the stage of administrative approval; CSPC Ouyi Pharmaceutical, Artex (Shanghai) and the Beijing Representative Office of Dr.

Source: CDE official website, Minet database

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.